LGD-3303

LGD-3303 Product Description — Research Use Only

LGD-3303 is a research compound studied as a selective androgen receptor modulator, commonly known as a SARM. It is not a peptide, but it is often grouped within peptide and research-compound catalogs because of its use in hormone-signaling, anabolic-pathway, and body-composition-related research.

Research on LGD-3303 has most commonly focused on androgen receptor activity, muscle-support pathways, bone-density research, lean-mass markers, tissue-selective anabolic signaling, and hormone-response studies. Published research describes LGD-3303 as an orally available nonsteroidal SARM studied for tissue-selective androgen receptor activity, particularly in muscle and bone-related models.

LGD-3303 is commonly studied for:

• Androgen receptor activity — how the compound interacts with androgen receptor pathways

• Muscle-support pathways — signals connected to muscle growth, repair, and protein balance

• Lean-mass research — markers related to lean tissue and body-composition changes

• Bone-support pathways — research involving bone strength, density, and maintenance

• Tissue selectivity — how activity may differ between muscle, bone, and other tissues

• Anabolic signaling — pathways connected to tissue growth, repair, and recovery response

• Hormone-response research — how androgen-related pathways influence biological signaling

LGD-3303 is commonly studied because SARMs are designed to activate androgen receptor pathways in a more tissue-selective way than traditional steroidal androgens. LGD-3303 research has reported anabolic effects in muscle and cortical bone models, while broader SARM literature describes the class as being investigated for muscle and bone activity with reduced prostate-related growth effects compared with testosterone-like compounds.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.